{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:53:45Z","timestamp":1792479225865,"version":"4.5.0"},"reference-count":27,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>The Brazilian Public Health System (BPHS) provides sole health coverage for approximately 77% of the population. Analyzing BPHS data enables nationwide assessment of epidemiology, treatment patterns, and costs for men with prostate cancer (PCa).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We conducted a retrospective, population-based cohort study using linked administrative data from the BPHS Database DATASUS for patients with PCa treated in the BPHS from January 1, 2008, to March 31, 2023. Variables include demographics, clinical features, stage, treatments, and health care utilization. The primary objective was to evaluate the impact of race on stage at diagnosis, treatment delivery, and treatment costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      A total of 670,205 patients with PCa were treated during the study period; 277,030 (41.4%) were White and 393,175 (58.6%) non-White. Mean age at diagnosis was 72.9 years (40-99). Approximately 56% were diagnosed with stage I-III disease (56.1%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      55.5%), and 21% with metastatic disease (19.7%\n                      <jats:italic toggle=\"yes\">v<\/jats:italic>\n                      21.2%), with non-White men more frequently presenting with advanced stage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). White men more commonly received local therapy in stage I, whereas non-White men received local therapy more frequently in stage III (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Among 125,759 men with stage IV disease who received systemic therapy, only 22,393 (17.8%) received docetaxel, while use of first-generation antiandrogens and estrogens remained high (25%). Total PCa-directed expenditures reached In$ 1.83 billion, with mean costs 16.2% higher for White patients than for non-White patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>In the BPHS, race was associated with more advanced stages at diagnosis and differences in treatment delivery. High rates of de novo metastatic disease, underuse of docetaxel, and persistent use of agents without survival benefit highlight urgent gaps in PCa care. These findings may guide PCa policy in Brazil and other low- and middle-income countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00712","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:59:08Z","timestamp":1780084748000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-848X","authenticated-orcid":true,"given":"Daniel","family":"Herchenhorn","sequence":"first","affiliation":[{"name":"Oncologia DOr\/IDOR, Rio de Janeiro, Brazil"},{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-573X","authenticated-orcid":true,"given":"Haonne","family":"Abboud","sequence":"additional","affiliation":[{"name":"Oncologia DOr\/IDOR, Rio de Janeiro, Brazil"},{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5194-8321","authenticated-orcid":true,"given":"Vinicius","family":"Freire","sequence":"additional","affiliation":[{"name":"Oncologia DOr\/IDOR, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5500-9385","authenticated-orcid":true,"given":"Juliana","family":"Tarouquella","sequence":"additional","affiliation":[{"name":"Oncologia DOr\/IDOR, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6621-8251","authenticated-orcid":true,"given":"Fernando Sabino M","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"},{"name":"Hospital S\u00edrio-Liban\u00eas, Bras\u00edlia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre P","family":"Fay","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"},{"name":"Escola de Medicina da PUCRS, Hospital Nora Teixeira, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Lu\u00eds Reis","family":"Freitas","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina da Universidade de S\u00e3o Paulo, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0581-7963","authenticated-orcid":true,"given":"Rana R.","family":"Mckay","sequence":"additional","affiliation":[{"name":"University of California, San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Rose","sequence":"additional","affiliation":[{"name":"University of California, San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo F","family":"Carvalhal","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"},{"name":"Escola de Medicina da PUCRS, Hospital Nora Teixeira, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-4261","authenticated-orcid":true,"given":"Igor","family":"Morbeck","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"},{"name":"Oncolinicas &amp; CO, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4288-9018","authenticated-orcid":true,"given":"Fernando Cotait","family":"Maluf","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"},{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3216-7713","authenticated-orcid":true,"given":"Vinicius Carrera","family":"Souza","sequence":"additional","affiliation":[{"name":"Oncologia DOr\/IDOR, Rio de Janeiro, Brazil"},{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-5486","authenticated-orcid":true,"given":"Douglas","family":"Valverde","sequence":"additional","affiliation":[{"name":"Healthtech Solutions, TechTrials, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elcio Fernandes","family":"Firmino","sequence":"additional","affiliation":[{"name":"Healthtech Solutions, TechTrials, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Deeke","family":"Sasse","sequence":"additional","affiliation":[{"name":"Grupo SONHE, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2480-353X","authenticated-orcid":true,"given":"Diogo","family":"Bastos","sequence":"additional","affiliation":[{"name":"Latin America Cooperative Oncology Group (LACOG)\u2014Genitourinary Tumors, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-8204","authenticated-orcid":true,"given":"Nick","family":"James","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_6_3_2","volume-title":"Estimativa 2023: Incid\u00eancia De C\u00e2ncer No Brasil","author":"Instituto Nacional de C\u00e2ncer (Brasil)","year":"2022","unstructured":"Instituto Nacional de C\u00e2ncer (Brasil): Estimativa 2023: Incid\u00eancia De C\u00e2ncer No Brasil. Rio de Janeiro, INCA Instituto Nacional de C\u00e2ncer, 2022"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.02.054"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.09.026"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00948-x"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/01419870.2011.607503"},{"key":"e_1_3_6_8_2","first-page":"55","volume-title":"Desenvolvimento Humano Nas Macrorregi\u00f5es Brasileiras: 2016","year":"2016","unstructured":"Desenvolvimento Humano Nas Macrorregi\u00f5es Brasileiras: 2016. Bras\u00edlia, PNUD; IPEA; FJP, 2016, 55"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31243-7"},{"key":"e_1_3_6_10_2","unstructured":"SIB-Sistema de Informa\u00e7\u00f5es de Benefici\u00e1rios: Ag\u00eancia Nacional de Sa\u00fade Suplementar. https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/perfil-do-setor\/dados-gerais"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311x00084216"},{"key":"e_1_3_6_12_2","first-page":"e00182119","article-title":"After all, how many nationwide health information systems are there in Brazil?","volume":"37","author":"Coelho Neto GC","year":"2021","unstructured":"Coelho Neto GC, Chioro A: After all, how many nationwide health information systems are there in Brazil? Cad Saude Publica 37:e00182119, 2021","journal-title":"Cad Saude Publica"},{"key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"e20233545","DOI":"10.1590\/0100-6991e-20233545-en","article-title":"Limitations of using the DATASUS database as a primary source of data in surgical research: A scoping review review","volume":"50","author":"Viana SW","year":"2023","unstructured":"Viana SW, Faleiro MD, Mendes ALF, et al: Limitations of using the DATASUS database as a primary source of data in surgical research: A scoping review review. Rev Col Bras Cir 50:e20233545, 2023","journal-title":"Rev Col Bras Cir"},{"key":"e_1_3_6_14_2","first-page":"100298","article-title":"Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study","volume":"13","author":"Quaresma AB","year":"2022","unstructured":"Quaresma AB, Damiao AOMC, Coy CSR, et al: Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Lancet Reg Health Am, 13:100298, 2022","journal-title":"Lancet Reg Health Am"},{"key":"e_1_3_6_15_2","article-title":"Demographic and clinical outcomes of Brazilian patients with stage III or IV Non-small-cell lung cancer: Real-world evidence study on the basis of deterministic linkage approach","author":"Ferreira CG","unstructured":"Ferreira CG, Abadi MD, Serra FB, et al: Demographic and clinical outcomes of Brazilian patients with stage III or IV Non-small-cell lung cancer: Real-world evidence study on the basis of deterministic linkage approach. JCO Glob Oncol 10.1200\/go.21.00228","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.08.085"},{"key":"e_1_3_6_17_2","volume-title":"OECD Data","author":"Organisation for Economic Co-operation and Development (OECD)","year":"2024","unstructured":"Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP) [indicator]. OECD Data. OECD 2024. https:\/\/data-explorer.oecd.org\/"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.11.023"},{"key":"e_1_3_6_19_2","volume-title":"Data source(s): SEER incidence data, November 2022 Submission (1975-2020), and 22 SEER registries","author":"Surveillance Research Program, National Cancer Institute","year":"2023","unstructured":"Surveillance Research Program, National Cancer Institute: SEER Explorer: An interactive website for SEER cancer statistics. Data source(s): SEER incidence data, November 2022 Submission (1975-2020), and 22 SEER registries; 2023. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21874"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0228"},{"key":"e_1_3_6_22_2","volume-title":"Diretrizes Diagn\u00f3sticas e Terap\u00eauticas do Adenocarcinoma de Pr\u00f3stata. Portaria n\u00b0 498","author":"Minist\u00e9rio da Sa\u00fade Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade","year":"2016","unstructured":"Minist\u00e9rio da Sa\u00fade Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade: Diretrizes Diagn\u00f3sticas e Terap\u00eauticas do Adenocarcinoma de Pr\u00f3stata. Portaria n\u00b0 498. 2016 https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/protocolos-clinicos-e-diretrizes-terapeuticas-pcdt\/arquivos\/2016\/ddt_adenocarcinoma_prostata.pdf"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2016.251"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2015.0690"},{"key":"e_1_3_6_25_2","article-title":"Surgical castration as an alternative to improve systemic treatment for advanced prostate cancer: A window of opportunity for developing countries","author":"Monteiro FSM","unstructured":"Monteiro FSM, Sasse AD, Araujo DV, et al: Surgical castration as an alternative to improve systemic treatment for advanced prostate cancer: A window of opportunity for developing countries. JCO Glob Oncol 10.1200\/GO-24-00319","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.08.3100"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00651-2"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fruro.2022.1020215"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:59:14Z","timestamp":1780516754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1200\/GO-25-00712"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00712","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500712"}}